DENNIS CARROLL, Director, Global Health Security and Development Unit, USAID

HILLARY CARTER, Director for Countering Biological Threats, National Security Council/The White House

TRUE CLAYCOMBE, Policy Manager, Friends of the Global Fight Against AIDS, Tuberculosis and Malaria

JOSEPH DAMOND, Senior Vice President, International Affairs, Biotechnology Innovation Organization

VICTOR DZAU, President, US National Academy of Medicine (NAM)

JOSE FERNANDEZ, Pandemic and Emerging Threats, Office of Global Affairs, US Department of Health and Human Services

JAMES GANNON, Executive Director, Japan Center for International Exchange (JCIE/USA)

MATTHEW GOODMAN, Senior Adviser for Asian Economics, Center for Strategic and International Studies; former Coordinator for APEC and the East Asia Summit and Director for International Economics, National Security Council/The White House

MICHAEL GREEN, Senior Vice President for Asia and Japan Chair, CSIS; former Special Assistant to the President and Senior Director for Asia, National Security Council/The White House

WALLACE “CHIP” GREGSON, Senior Advisor, Avascent Global Advisors; former Assistant Secretary of Defense for Asian and Pacific Affairs; former Commanding General. Marine Corps Forces Pacific

JOHN HAMRE, President & CEO, CSIS

F. GRAY HANDLEY, Associate Director for International Research Affairs, National Institute for Allergy and Infectious Diseases, National Institute for Health (NIH) SEMA HASHEMI, Director, Office of Regional and Country Affairs, Office of International Programs, US Food and Drug Administration (FDA)

YOSHIKAZU HAYASHI, Associate Center Director for New Drug Review, Pharmaceuticals and Medical Device Agency (PMDA)

AUDREY JACKSON, Senior Fellow, Global Health Policy Center, CSIS

SHIRA KILCOYNE, Director, Government Affairs International, GlaxoSmithKline

PETER KILMARX, Deputy Director, Fogarty International Center, NIH

IRENE KOEK, Senior Deputy Assistant Administrator for Global Health, USAID

TATSUYA KONDO, Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)

CLAUDIO LILIENFELD, Director, Government Affairs for Asia, Gilead Sciences; former Deputy Assistant/Acting Assistant US Trade Representative for South and Central Asia

JOHN MONAHAN, Senior Advisor for Global Health to the Georgetown University President; former Special Advisor for Global Health Partnerships, US Department of State

J. STEPHEN MORRISON, Senior Vice President and Director, Global Health Policy Center, CSIS

HIROKI NAKATANI, Project Professor and Senior Researcher, Global Research Institute (KGRI), Keio University; former Assistant Director-General, World Health Organization

ATSUYOKI OIKE, Deputy Chief of Mission, Embassy of Japan

AKIO OKAWARA, President & CEO, Japan Center for International Exchange (JCIE/Japan)

STEPHEN OSTROFF, Acting Commissioner, US Food and Drug Administration (FDA)

STEVEN PHILLIPS, Center for Strategic and International Studies; former Medical Director, Exxon Mobil Corporation

YASUHISA SHIOZAKI, Minister of Health, Labour and Welfare of Japan

MAKOTO SUEMATSU, President, Japan Agency for Medical Research and Development (AMED)

NICHOLAS SZECHENYI, Deputy Director, Japan Chair, CSIS

JORDAN TAPPERO, Director, Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention (CDC)

KEIZO TAKEMI, Member, House of Councillors of Japan

RAJIV VENKAYYA, President of the Global Vaccine Business Unit, Takeda Pharmaceuticals; former Special Assistant to the President and Senior Director for Biodefense, National Security Council/The White House

TADATAKA (TACHI) YAMADA, Venture Partner, Frazier Life Sciences

NAOKO YAMAMOTO, Assistant Minister for Global Health and Health Industry Strategy, Ministry of Health, Labour, and Welfare of Japan

TIM ZIEMER, Senior Director for Global Health Security and Biothreats, National Security Council/The White House; former Coordinator, US President’s Malaria Initiative; former Rear Admiral, United States Navy (Ret.)